Penalties for False Drug Ads Online: Influencer Misinformation Crackdown.
This law establishes civil penalties for social media influencers and healthcare providers who knowingly promote prescription drugs with false information or fail to disclose crucial details about side effects. It ensures that drug advertisements seen online are as complete and accurate as traditional ads, protecting citizens from misleading health claims. Furthermore, all payments from drug manufacturers to influencers and telehealth companies for drug promotion must be publicly reported, increasing financial transparency.
Key points
Financial penalties for influencers and healthcare providers who post false or misleading paid advertisements for prescription drugs on social media.
Online drug promotions must include a brief summary of side effects, contraindications, and effectiveness, just like traditional advertisements.
Increased transparency: Drug manufacturers must publicly report payments made to influencers and telehealth companies for promoting covered drugs.
FDA gains authority to actively monitor and enforce rules against deceptive drug advertising across social media platforms.
Expired
Additional Information
Print number: 118_S_5040
Sponsor: Sen. Durbin, Richard J. [D-IL]
Process start date: 2024-09-12